Searching for the second best graft for coronary artery bypass surgery: A network meta-analysis of randomized controlled trials

Umberto Benedetto, Shahzad G. Raja, Alberto Albanese, Mohammed Amrani, Giuseppe Biondi-Zoccai, Giacomo Frati

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: There is a lack of unequivocal evidence basis for selecting the best second conduit in coronary artery bypass grafting (CABG). We thus aimed to perform head-to-head relative effect estimate on angiographic outcomes for second conduits, including the right internal mammary artery (RIMA), radial artery (RA), right gastroepiploic artery (RGEA) and saphenous vein graft (SVG) by means of network meta-analysis of randomized controlled trials (RCTs). METHODS: Databases were searched for RCTs comparing angiographic outcomes (≥4 weeks) of second conduits in CABG. Odds ratios (95% confidence intervals) were computed with Markov Chain Monte Carlo simulation. RESULTS: A total of nine RCTs were identified, including 2780 patients and 1620 angiographic results available for analysis to compare RIMA (n = 145) versus RA (n = 871) versus RGEA (n = 92) versus SVG (n = 845). The mean time to angiographic follow-up ranged from 1 to 7.7 years. An SVG was significantly associated with a 4-fold (1.67-16.00) and 3-fold (0.78-22.20) increased risk of late (≥4 years) functional graft occlusion when compared with the RIMA and RA, respectively. A RIMA was associated with a non-significant 27% absolute risk reduction for functional graft occlusion when compared with the RA. CONCLUSIONS: The present network meta-analysis consistently demonstrated an angiographic superiority of RIMA and RA over SVG. The RIMA is expected to achieve a better patency rate than the RA, but further studies are needed.

Original languageEnglish
Article numberezu111
Pages (from-to)59-65
Number of pages7
JournalEuropean Journal of Cardio-thoracic Surgery
Volume47
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Radial Artery
Mammary Arteries
Coronary Artery Bypass
Randomized Controlled Trials
Saphenous Vein
Transplants
Gastroepiploic Artery
Numbers Needed To Treat
Markov Chains
Network Meta-Analysis
Odds Ratio
Databases
Confidence Intervals

Keywords

  • Coronary artery bypass grafting
  • Coronary disease
  • Meta-analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Searching for the second best graft for coronary artery bypass surgery : A network meta-analysis of randomized controlled trials. / Benedetto, Umberto; Raja, Shahzad G.; Albanese, Alberto; Amrani, Mohammed; Biondi-Zoccai, Giuseppe; Frati, Giacomo.

In: European Journal of Cardio-thoracic Surgery, Vol. 47, No. 1, ezu111, 2014, p. 59-65.

Research output: Contribution to journalArticle

Benedetto, Umberto ; Raja, Shahzad G. ; Albanese, Alberto ; Amrani, Mohammed ; Biondi-Zoccai, Giuseppe ; Frati, Giacomo. / Searching for the second best graft for coronary artery bypass surgery : A network meta-analysis of randomized controlled trials. In: European Journal of Cardio-thoracic Surgery. 2014 ; Vol. 47, No. 1. pp. 59-65.
@article{9fef5d5f019c449994990e5ffc773ed8,
title = "Searching for the second best graft for coronary artery bypass surgery: A network meta-analysis of randomized controlled trials",
abstract = "OBJECTIVES: There is a lack of unequivocal evidence basis for selecting the best second conduit in coronary artery bypass grafting (CABG). We thus aimed to perform head-to-head relative effect estimate on angiographic outcomes for second conduits, including the right internal mammary artery (RIMA), radial artery (RA), right gastroepiploic artery (RGEA) and saphenous vein graft (SVG) by means of network meta-analysis of randomized controlled trials (RCTs). METHODS: Databases were searched for RCTs comparing angiographic outcomes (≥4 weeks) of second conduits in CABG. Odds ratios (95{\%} confidence intervals) were computed with Markov Chain Monte Carlo simulation. RESULTS: A total of nine RCTs were identified, including 2780 patients and 1620 angiographic results available for analysis to compare RIMA (n = 145) versus RA (n = 871) versus RGEA (n = 92) versus SVG (n = 845). The mean time to angiographic follow-up ranged from 1 to 7.7 years. An SVG was significantly associated with a 4-fold (1.67-16.00) and 3-fold (0.78-22.20) increased risk of late (≥4 years) functional graft occlusion when compared with the RIMA and RA, respectively. A RIMA was associated with a non-significant 27{\%} absolute risk reduction for functional graft occlusion when compared with the RA. CONCLUSIONS: The present network meta-analysis consistently demonstrated an angiographic superiority of RIMA and RA over SVG. The RIMA is expected to achieve a better patency rate than the RA, but further studies are needed.",
keywords = "Coronary artery bypass grafting, Coronary disease, Meta-analysis",
author = "Umberto Benedetto and Raja, {Shahzad G.} and Alberto Albanese and Mohammed Amrani and Giuseppe Biondi-Zoccai and Giacomo Frati",
year = "2014",
doi = "10.1093/ejcts/ezu111",
language = "English",
volume = "47",
pages = "59--65",
journal = "European Journal of Cardio-thoracic Surgery",
issn = "1010-7940",
publisher = "European Association for Cardio-Thoracic Surgery",
number = "1",

}

TY - JOUR

T1 - Searching for the second best graft for coronary artery bypass surgery

T2 - A network meta-analysis of randomized controlled trials

AU - Benedetto, Umberto

AU - Raja, Shahzad G.

AU - Albanese, Alberto

AU - Amrani, Mohammed

AU - Biondi-Zoccai, Giuseppe

AU - Frati, Giacomo

PY - 2014

Y1 - 2014

N2 - OBJECTIVES: There is a lack of unequivocal evidence basis for selecting the best second conduit in coronary artery bypass grafting (CABG). We thus aimed to perform head-to-head relative effect estimate on angiographic outcomes for second conduits, including the right internal mammary artery (RIMA), radial artery (RA), right gastroepiploic artery (RGEA) and saphenous vein graft (SVG) by means of network meta-analysis of randomized controlled trials (RCTs). METHODS: Databases were searched for RCTs comparing angiographic outcomes (≥4 weeks) of second conduits in CABG. Odds ratios (95% confidence intervals) were computed with Markov Chain Monte Carlo simulation. RESULTS: A total of nine RCTs were identified, including 2780 patients and 1620 angiographic results available for analysis to compare RIMA (n = 145) versus RA (n = 871) versus RGEA (n = 92) versus SVG (n = 845). The mean time to angiographic follow-up ranged from 1 to 7.7 years. An SVG was significantly associated with a 4-fold (1.67-16.00) and 3-fold (0.78-22.20) increased risk of late (≥4 years) functional graft occlusion when compared with the RIMA and RA, respectively. A RIMA was associated with a non-significant 27% absolute risk reduction for functional graft occlusion when compared with the RA. CONCLUSIONS: The present network meta-analysis consistently demonstrated an angiographic superiority of RIMA and RA over SVG. The RIMA is expected to achieve a better patency rate than the RA, but further studies are needed.

AB - OBJECTIVES: There is a lack of unequivocal evidence basis for selecting the best second conduit in coronary artery bypass grafting (CABG). We thus aimed to perform head-to-head relative effect estimate on angiographic outcomes for second conduits, including the right internal mammary artery (RIMA), radial artery (RA), right gastroepiploic artery (RGEA) and saphenous vein graft (SVG) by means of network meta-analysis of randomized controlled trials (RCTs). METHODS: Databases were searched for RCTs comparing angiographic outcomes (≥4 weeks) of second conduits in CABG. Odds ratios (95% confidence intervals) were computed with Markov Chain Monte Carlo simulation. RESULTS: A total of nine RCTs were identified, including 2780 patients and 1620 angiographic results available for analysis to compare RIMA (n = 145) versus RA (n = 871) versus RGEA (n = 92) versus SVG (n = 845). The mean time to angiographic follow-up ranged from 1 to 7.7 years. An SVG was significantly associated with a 4-fold (1.67-16.00) and 3-fold (0.78-22.20) increased risk of late (≥4 years) functional graft occlusion when compared with the RIMA and RA, respectively. A RIMA was associated with a non-significant 27% absolute risk reduction for functional graft occlusion when compared with the RA. CONCLUSIONS: The present network meta-analysis consistently demonstrated an angiographic superiority of RIMA and RA over SVG. The RIMA is expected to achieve a better patency rate than the RA, but further studies are needed.

KW - Coronary artery bypass grafting

KW - Coronary disease

KW - Meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=84919992125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919992125&partnerID=8YFLogxK

U2 - 10.1093/ejcts/ezu111

DO - 10.1093/ejcts/ezu111

M3 - Article

C2 - 24686003

AN - SCOPUS:84919992125

VL - 47

SP - 59

EP - 65

JO - European Journal of Cardio-thoracic Surgery

JF - European Journal of Cardio-thoracic Surgery

SN - 1010-7940

IS - 1

M1 - ezu111

ER -